Recursion Pharmaceuticals P/TBV

Price to Tangible Book Value (P/TBV) of Recursion Pharmaceuticals is 1.88 in 2026.

Price to Tangible Book Value (P/TBV) of Recursion Pharmaceuticals changed from 3.30 to 1.88, representing a -43.22% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Price to Tangible Book Value (P/TBV) Recursion Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

P/TBV compares the stock price to tangible book value per share, excluding goodwill and intangibles. It provides a conservative asset-based valuation.

To evaluate Price to Tangible Book Value (P/TBV)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Price to Tangible Book Value (P/TBV).

A 'good' varies by industry and company stage. On Eulerpool, you can compare Price to Tangible Book Value (P/TBV)'s Recursion Pharmaceuticals with sector peers and the industry average to assess whether it is attractive.